Outset Medical is looking to expand its Tablo label to include home use by sponsoring a 40-patient investigational device exemption (IDE) trial for the all-in-one dialysis device.
Read the full article » | Posted 05/09/2017
- When Pigs Fly… Posted 09/15/2017
- Home Dialyzors United Helps Guide the Kidney Project Posted 09/15/2017
- DIY Dialysis? Posted 08/17/2017
- VasQ and A Posted 08/17/2017
- Transitioning Home Posted 07/14/2017